Literature DB >> 15249749

[Problems of randomized studies in complementary medicine demonstrated in a study on mistletoe treatment of patients with breast cancer].

I Gerhard1, U Abel, A Loewe-Mesch, S Huppmann, J J Kuehn.   

Abstract

BACKGROUND: Prospective randomized studies on mistletoe therapy repeatedly demonstrated that there is a basic problem in the matter of enrolling the appropriate number of patients within a reasonable amount of time. Most studies have to face this problem. However, recent experience suggests that this problem is more pronounced in the case of mistletoe treatment of cancer patients.
OBJECTIVE: Possibility of recruitment and randomization of breast cancer patients for a mistletoe study. PATIENTS: During a period of 28 months every patient was registered who was admitted to the Gynecological Hospital of the University of Heidelberg because of suspected cancer.
RESULTS: Out of 1,922 patients who were operated on for breast tumor, 521 first met the inclusion and exclusion criteria. 154 out of these 521 patients agreed to take part in the study. After availability of the final results on tumor staging and the therapy plan for conventional treatment, 80 out of the 154 women had to be excluded from the study. From the remaining 74 patients (48%), however, only 29 (39%) would have agreed to take part in a randomized mistletoe study.
CONCLUSIONS: This confirms our suspicion that the difficulties of enrollment and randomization in the case of mistletoe studies exceed those of studies conducted in conventional oncology. The reasons for this dramatic effect and the possibility of alternative study designs are discussed. Copyright 2004 S. Karger GmbH, Freiburg

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15249749     DOI: 10.1159/000079444

Source DB:  PubMed          Journal:  Forsch Komplementarmed Klass Naturheilkd        ISSN: 1424-7364


  5 in total

1.  Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review.

Authors:  Thomas Ostermann; Christa Raak; Arndt Büssing
Journal:  BMC Cancer       Date:  2009-12-18       Impact factor: 4.430

2.  Classical homeopathy in the treatment of cancer patients--a prospective observational study of two independent cohorts.

Authors:  Matthias Rostock; Johannes Naumann; Corina Guethlin; Lars Guenther; Hans H Bartsch; Harald Walach
Journal:  BMC Cancer       Date:  2011-01-17       Impact factor: 4.430

3.  Mistletoe Preparation Iscador: Are there Methodological Concerns with Respect to Controlled Clinical Trials?

Authors:  Renatus Ziegler
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-04       Impact factor: 2.629

4.  Contributing to Global Health: Development of a Consensus-Based Whole Systems Research Strategy for Anthroposophic Medicine.

Authors:  G S Kienle; E Ben-Arye; B Berger; C Cuadrado Nahum; T Falkenberg; G Kapócs; H Kiene; D Martin; U Wolf; H Szöke
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-12       Impact factor: 2.629

5.  Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a multicentre, parallel group, double-blind, randomised, placebo-controlled clinical trial (MISTRAL).

Authors:  Kathrin Wode; Johanna Hök Nordberg; Gunver S Kienle; Nils O Elander; Britt-Marie Bernhardson; Berit Sunde; Lena Sharp; Roger Henriksson; Per Fransson
Journal:  Trials       Date:  2020-09-11       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.